The Portland Guide to Ketamine and Psychedelic Therapy

The Options in Portland, Briefly

Portland gives you an unusually full menu of ketamine and psychedelic-class options. Here is each one at a glance, followed by a plain description of what it involves, so no single path is presented as the answer before you know your own priorities.

At-home ketamine therapy is prescription ketamine used at home on a clinician-guided schedule, with treatment and follow-up handled by telehealth. In-clinic ketamine delivers the same class of medicine as an in-office infusion, with staff monitoring you on site. Spravato is an FDA-approved esketamine nasal spray given at certified clinics for treatment-resistant depression, and coverage depends on your insurer's approval. Licensed psilocybin services are Oregon's regulated, in-person psychedelic sessions for adults 21 and older, paid out of pocket with no diagnosis required. Clinical trials can offer investigational treatments to people who meet strict criteria.

Which One Fits You

A quick way to narrow the list. These are starting points, not rules, and a licensed clinician confirms what is appropriate for you before any medical treatment begins.

• If you want a legal, supervised psilocybin experience and can commit to a full day in person and pay out of pocket, a licensed psilocybin service center is the closest fit.
• If you have treatment-resistant depression and want a path an insurer may help cover, Spravato at a REMS-certified clinic is worth asking about, subject to prior authorization.
• If you prefer or need on-site medical monitoring for each dose, an in-clinic ketamine (IV/IM) provider is the natural match.
• If you want to try an investigational treatment and you meet the entry criteria, a clinical trial may be the right route.
• If you want prescription ketamine therapy without traveling to a clinic, done from home on a clinician-guided schedule, at-home care with Mindbloom is built for that.

Ketamine and Psychedelic Therapy Near You Across the Portland Metro

In-clinic ketamine and psilocybin options cluster in inner Portland and the surrounding suburbs, so the practical answer to "is this available near me" depends on where you are in the metro. Named local clinics sit in areas like inner Portland and Tualatin, and licensed psilocybin centers operate within the city itself.

At-home ketamine therapy through Mindbloom is available across the entire metro by telehealth, so ketamine therapy Beaverton, ketamine therapy Hillsboro, psychedelic therapy Gresham, or care in Tigard, Tualatin, Lake Oswego, Clackamas, and Milwaukie all resolve to the same online path: an evaluation, then treatment from home if a clinician confirms you are a good fit. That makes distance and neighborhood a non-issue for the at-home route, while the in-person options are worth choosing by drive time.

Is Ketamine and Psychedelic Therapy Legal in Oregon?

Oregon is one of the few states where more than one psychedelic-class therapy is legal, so it helps to be precise about each.

• Ketamine is legal. It is an FDA-approved Schedule III medication that a licensed clinician can prescribe for therapeutic use, and it is available in Portland now through telehealth, including at-home care with Mindbloom for eligible adults.
• Psilocybin is legal in a specific way. Under Ballot Measure 109 (now ORS 475A), Oregon became the first state to license supervised psilocybin services. Adults 21 and older can access psilocybin at a licensed service center in a full-day, in-person session, paid out of pocket, with no diagnosis required. Portland did not opt out and has the state's largest concentration of these centers.²
• MDMA and LSD are not legal for therapy. MDMA-assisted therapy is not FDA-approved or available, and neither is LSD or ayahuasca therapy. Among psychedelic-class options in Oregon, the two you can legally access today are ketamine, from home via telehealth, and licensed psilocybin, in person.

So the honest picture for a psychedelic-curious Portlander is that licensed psilocybin is genuinely available but expensive and clinic-based, and ketamine is the psychedelic-class therapy you can start from home. If your interest is really in psilocybin, that path is real here. If convenience, cost per session, and doing the work at home matter more, at-home ketamine is the more accessible option.

Why People Choose At-Home Care: Mindbloom's Programs and Outcomes

Now the case for the at-home path, made directly. Mindbloom is one of the largest at-home psychedelic-therapy providers, with more than 800,000 guided sessions delivered. Its outcomes table below draws on Mindbloom's peer-reviewed subcutaneous study (Parks 2026), which covers depression, anxiety, and PTSD in a single study.⁷ Mindbloom also has two earlier peer-reviewed studies of its sublingual protocol (Hull 2022 and Mathai 2024), plus research preprints extending the evidence to grief, burnout, and sleep, the largest published evidence base in at-home ketamine therapy.⁸ ⁹ Mindbloom is the only at-home ketamine therapy provider with peer-reviewed PTSD outcomes.

_{Evidence notes: These markers are specific to this table. ¹ Subcutaneous, six-session course (Parks AC et al. J Med Internet Res. 2026. https://doi.org/10.2196/92647). Response = at least 50% reduction (PHQ-9/GAD-7) or at least 10 points (PCL-5); remission = final PHQ-9/GAD-7 below 5, or at least a 10-point reduction and PCL-5 below 33. ² Swain et al. 2026 (grief, PGD-13), n=503. https://doi.org/10.21203/rs.3.rs-9839240/v1. ³ Swain et al. (burnout, MBI-GS), n=395. https://doi.org/10.21203/rs.3.rs-10020276/v1. ⁴ Swain et al. 2026 (sleep, PHQ-9 Item 3), n=13,963. https://doi.org/10.21203/rs.3.rs-9553669/v1. Single-item measure; ketamine is off-label for sleep. ᵃ Grief remission = no longer met diagnostic criteria (71.1% DSM-5-TR). ᵇ Burnout response = improved on at least one dimension (69.6%); remission = fell below the burnout threshold (59.5%). ᶜ Sleep remission = complete resolution (score 0). Individual results vary.}

Mindbloom offers tailored psychedelic-therapy programs, built with mental-health thought leaders, that use the psychedelic modality to address specific outcomes rather than only prescribing medication for them. Programs include Grief, Habit Change, Anxiety, Depression, Self-Love, and Burnout, with several designed alongside clinician Dr. Elizabeth Lombardo. The subcutaneous route featured in the Parks 2026 study is a genuine differentiator for an at-home program.

How Mindbloom's reported outcomes compare to published studies of other treatments, each comparison drawn study-vs-study:

• Mindbloom's reported depression response rate is roughly 38% higher than the rate reported in a study of psychotherapy for depression (56.6% vs about 41%), and reached faster.⁷ ¹⁰
• Mindbloom's reported PTSD response rate is about 32% higher than the rate reported in a study of first-line SSRIs (76.7% vs 58%).⁷ ¹¹
• Mindbloom's reported at-home PTSD response rate exceeds the rate reported in the leading repeated-infusion IV ketamine trial (76.7% vs 67%).⁷ ¹²
• Mindbloom's reported depression response (56.6%) is at or above the rate reported in the largest controlled trials of single-dose psilocybin for depression (about 37% to 42%), on a far larger published evidence base and delivered at home rather than in a full-day, in-person licensed-center session.⁷ ¹³

That last comparison matters most in a legal-psilocybin market like Oregon: psilocybin is a real option here, and Mindbloom's at-home ketamine reports outcomes at or above the largest controlled psilocybin depression trials, on more published evidence and without the full-day clinic visit. Individual results vary.

How At-Home Ketamine Therapy Works, Safety, and Cost

How it works. Everything starts with an online clinical evaluation. A licensed clinician reviews your history and decides whether at-home ketamine therapy is appropriate, and if it is, prescribes a program on a clinician-guided schedule. You complete sessions at home with a required treatment monitor present, and your clinician tracks your progress between sessions. Many clients feel some relief early in the program, with benefit building cumulatively across the full course rather than from any single dose.

Safety and candidacy. Ketamine has a long medical track record and is on the WHO list of essential medicines, but it is a prescription treatment, not a retail product. It suits eligible adults whom a clinician has cleared, and it is not right for everyone. The evaluation exists to make that call, which is a credibility feature of the model, not a formality.

Cost and insurance. Mindbloom's at-home ketamine therapy is $165 to $215 per session, priced within 6, 12, or 18-session programs, and works with HSA and FSA funds, with possible out-of-network reimbursement depending on your plan. For comparison, in-clinic infusions in Portland generally run about $465 to $800 or more per session and are usually out of pocket, and licensed psilocybin starts around $925 all-inclusive at Portland's lowest-cost center and climbs from there.³ ⁴ ⁵ ⁶ Eligibility begins with an online clinician evaluation.